ASCO has historically been a fiASCO. This has nothing to do with ASCO. This is isn't either a gold rush, CLDX management have been very diligent in creating a company with very good future, sometimes sacrificing short term interest of small investors like us.
Whip- It's not a gold rush, but a modern day equivalent- that is, a targeted immunotherapy rush. The model is working and Celldex is the best pure play in this area of reseach, has great fully-owned late-stage products, money in the bank and clout to make it happen. Happy to be here with you on this trek onward and upward.